{
    "organizations": [],
    "uuid": "0e134888a8ce24654b76046b997912f946a20f1c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hls-therapeutics-announces-qtrly-n/brief-hls-therapeutics-announces-qtrly-net-loss-0-19-per-common-share-idUSASC0A2JS",
    "ord_in_thread": 0,
    "title": "BRIEF-Hls Therapeutics Announces Qtrly Net Loss $0.19 Per Common Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - HLS Therapeutics Inc:\n* Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION * QTRLY NET LOSS $0.19 PER COMMON SHARE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-16T18:36:00.000+03:00",
    "crawled": "2018-05-17T14:38:39.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "hl",
        "therapeutic",
        "inc",
        "q1",
        "revenue",
        "million",
        "versus",
        "million",
        "qtrly",
        "net",
        "loss",
        "per",
        "common",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}